Patent · US Expired

4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof

US7084152B2 · kind B2 · utility

25Cited by

13References

30Claims

0Family size

Assignee

AMR Technology, Inc. · US

Inventors

James P. Beck · Zionsville, US
Anthony Pechulis · Guilderland, US
Arthur E. Harms · Niskayuna, US

Key dates

Filing date	Jul 11, 2001
Grant date	Aug 1, 2006
Priority date	—
Expiry date	Jul 11, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.